Novel PMS2 Pseudogenes Can Conceal Recessive Mutations Causing a Distinctive Childhood Cancer Syndrome

American Journal of Human Genetics

Volumn 74, Issue 5, 2004, Pages 954-964

  De Vos, Michel ^a   Hayward, Bruce E ^a   Picton, Susan ^b   Sheridan, Eamonn ^b   Bonthron, David T ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CAFE AU LAIT SPOT; CANCER SUSCEPTIBILITY; CASE REPORT; CENTROMERE; CHILDHOOD CANCER; DNA POLYMORPHISM; FAMILY; FEMALE; GENE DUPLICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTESTINE CANCER; MALE; MISMATCH REPAIR; NEUROECTODERM TUMOR; NUCLEOTIDE SEQUENCE; PMS2 PSEUDOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOGENE; SCHOOL CHILD;

EID: 2342506542     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/420796     Document Type: Article

References (56)

1. Baptiste M, Nasca P, Metzger B, Field N, MacCubbin P, Greenwald P, Armbrustmacher V, Waldman J, Carlton K (1989) Neurofibromatosis and other disorders among children with CNS tumors and their families. Neurology 39:487-492
2. Basil JB, Swisher EM, Herzog TJ, Rader JS, Elbendary A, Mutch DG, Goodfellow PJ (1999) Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability. Gynecol Oncol 74:395-399
3. Burwell RG, James NJ, Johnston DI (1982) Cafe-au-lait spots in schoolchildren. Arch Dis Child 57:631-632
4. Chadwick RB, Meek JE, Prior TW, Peltomaki P, de La Chapelle A (2000) Polymorphisms in a pseudogene highly homologous to PMS2. Hum Mutat 16:530
5. Chan GC, Nicholls JM, Lee AC, Chan LC, Lau YL (1996) Malignant peripheral neuroectodermal tumor in an infant with neurofibromatosis type 1. Med Pediatr Oncol 26:215-219
6. De Rosa M, Fasano C, Panariello L, Scarano MI, Belli G, Iannelli A, Ciciliano F, Izzo P (2000) Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene 19: 1719-1723
7. Dirks PB, Harris L, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT (1996) Supratentorial primitive neuroectodermal tumors in children. J Neurooncol 29:75-84
8. Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138-143
9. Glaab WE, Risinger JI, Umar A, Kunkel TA, Barrett JC, Tindall KR (1998) Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor. J Biol Chem 273:26662-26669
10. Guerrette S, Acharya S, Fishel R (1999) The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem 274:6336-6341
11. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus GJA, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW (1995) The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847
12. Harfe BD, Jinks-Robertson S (2000) DNA mismatch repair and genetic instability. Annu Rev Genet 34:359-399
13. Ho YS, Hsieh LL, Chen JS, Chang CN, Lee ST, Chiu LL, Chin TY, Cheng SC (1996) p53 gene mutation in cerebral primitive neuroectodermal tumor in Taiwan. Cancer Lett 104: 103-113
14. Horii A, Han HJ, Sasaki S, Shimada M, Nakamura Y (1994) Cloning, characterization and chromosomal assignment of the human genes homologous to yeast PMS1, a member of mismatch repair genes. Biochem Biophys Res Commun 204: 1257-1264
15. Jakacki RI (1999) Pineal and nonpineal supratentorial primitive neuroectodermal tumors. Childs Nerv Syst 15:586-591
16. Kato T, Yatagai F, Glickman BW, Tachibana A, Ikenaga M (1998) Specificity of mutations in the PMS2-deficient human tumor cell line HEC-1-A. Mutat Res 422:279-283
17. Kondo E, Horii A, Fukushige S (1999) The human PMS2L proteins do not interact with hMLH1, a major DNA mismatch repair protein. J Biochem (Tokyo) 125:818-825
18. Korf BR (1992) Diagnostic outcome in children with multiple cafe au lait spots. Pediatrics 90:924-927
19. Korf BR (2000) Malignancy in neurofibromatosis type 1. Oncologist 5:477-485
20. Kuramoto H, Tamura S, Notake Y (1972) Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol 114:1012-1019
21. Li GM, Modrich P (1995) Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci USA 92:1950-1954
22. Liu T, Yan H, Kuismanen S, Percesepe A, Bisgaard ML, Pedroni M, Benatti P, Kinzler KW, Vogelstein B, Ponz de Leon M, Peltomaki P, Lindblom A (2001) The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 61: 7798-7802
23. Marti TM, Kunz C, Fleck O (2002) DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191:28-41
24. Martinez-Lage JF, Salcedo C, Corral M, Poza M (2002) Medulloblastomas in neurofibromatosis type 1: case report and literature review. Neurocirugia (Astur) 13:128-131
25. Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Nagato M, Chong JM, Koike M, Terada T, Kawahara Y, Fukutome A, Tomiyama J, Chuganji Y, Momoi M, Utsunomiya J (1997) Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene 15:2877-2881
26. Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM (1997) Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci USA 94:3122-3127
27. National Institutes of Health (1988) Neurofibromatosis: conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575-578
28. Nicolaides NC, Carter KC, Shell BK, Papadopoulos N, Vogelstein B, Kinzler KW (1995) Genomic organization of the human PMS2 gene family. Genomics 30:195-206
29. Nicolaides NC, Littman SJ, Modrich P, Kinzler KW, Vogelstein B (1998) A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 18: 1635-1641
30. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80
31. Orellana C, Martinez F, Hernandez-Marti M, Castel V, Canete A, Prieto F, Badia L (1998) A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father. Cancer Genet Cytogenet 105:103-108
32. Osborne LR, Herbrick JA, Greavette T, Heng HH, Tsui LC, Scherer SW (1997) PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7. Genomics 45:402-406
33. Osborne LR, Li M, Pober B, Chitayat D, Bodurtha J, Mandel A, Costa T, Grebe T, Cox S, Tsui LC, Scherer SW (2001) A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet 29:321-325
34. Paulino AC (1999) Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer 86:135-141
35. Peltomaki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10: 735-740
36. Perilongo G, Felix CA, Meadows AT, Nowell P, Biegel J, Lange BJ (1993) Sequential development of Wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma and myeloid leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case report. Leukemia 7:912-915
37. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR (2002) Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature 415:436-442
38. Raffel C, McComb JG, Bodner S, Gilles FE (1989) Benign brain stem lesions in pediatric patients with neurofibromatosis: case reports. Neurosurgery 25:959-964
39. Raschle M, Marra G, Nystrom-Lahti M, Schar P, Jiricny J (1999) Identification of hMutLβ, a heterodimer of hMLH1 and hPMS1. J Biol Chem 274:32368-32375
40. Ricciardone MD, Ozcelik T, Cevher B, Ozdag H, Tuncer M, Gurgey A, Uzunalimoglu O, Cetinkaya H, Tanyeli A, Erken E, Ozturk M (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 59:290-293
41. Risinger JI, Umar A, Barrett JC, Kunkel TA (1995) A hPMS2 mutant cell line is defective in strand-specific mismatch repair. J Biol Chem 270:18183-18186
42. Risinger JI, Umar A, Glaab WE, Tindall KR, Kunkel TA, Barrett JC (1998) Single gene complementation of the hPMS2 defect in HEC-1-A endometrial carcinoma cells. Cancer Res 58:2978-2981
43. Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433-1443
44. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG (1999) Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 86:331-339
45. Schwartz S, Zhang Z, Frazer KA, Smit A, Riemer C, Bouck J, Gibbs R, Hardison R, Miller W (2000) PipMaker - a web server for aligning two genomic DNA sequences. Genome Res 10:577-586
46. Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O (1999) Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 8:2359-2368
47. Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A (2001) Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 19:2696-2704
48. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT (2000) Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 66:1403-1406
49. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680
50. Trimbath JD, Petersen GM, Erdman SH, Ferre M, Luce MC, Giardiello FM (2001) Cafe-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? Fam Cancer 1:101-105
51. Valero MC, de Luis O, Cruces J, Perez Jurado LA (2000) Fine-scale comparative mapping of the human 7q11.23 region and the orthologous region on mouse chromosome 5G: the low-copy repeats that flank the Williams-Beuren syndrome deletion arose at breakpoint sites of an evolutionary inversion(s). Genomics 69:1-13
52. Vilkki S, Tsao JL, Loukola A, Poyhonen M, Vierimaa O, Herva R, Aaltonen LA, Shibata D (2001) Extensive somatic microsatellite mutations in normal human tissue. Cancer Res 61:4541-4544
53. Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E, Puisieux A (1999) Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 59:294-297
54. Whiteside D, McLeod R, Graham G, Steckley JL, Booth K, Somerville MJ, Andrew SE (2002) A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res 62:359-362
55. Yamada NA, Castro A, Farber RA (2003) Variation in the extent of microsatellite instability in human cell lines with defects in different mismatch repair genes. Mutagenesis 18: 277-282
56. Yang HJ, Nam DH, Wang KC, Kim YM, Chi JG, Cho BK (1999) Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors. Childs Nerv Syst 15:377-383